New Hampshire HB1755 mandates reporting requirements for entities participating in the 340B Drug Pricing Program.
New Hampshire HB1755 establishes reporting requirements for entities participating in the federal 340B Drug Pricing Program. These entities must report annually to the Department of Health and Human Services and the Attorney General. The report includes details such as the entity's name, service address, and financial transactions related to the 340B program. The Department of Health and Human Services must then aggregate this data and submit a report to the Speaker of the House, the Senate President, and the House and Senate Clerk by November 15 each year.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.